Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001957799-23-000068
Filing Date
2023-05-12
Accepted
2023-05-12 16:24:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3885
  Complete submission text file 0001957799-23-000068.txt   5452
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
Aceragen, Inc. (Subject) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-31918 | Film No.: 23916176
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ACERAGEN, INC. 15 TW ALEXANDER DRIVE DURHAM NC 27709
Business Address
Chopra Atul (Reporting) CIK: 0001946240 (see all company filings)

Type: 144